Author + information
- Received August 4, 2017
- Revision received November 16, 2017
- Accepted November 22, 2017
- Published online June 25, 2018.
- Jennifer N.A. Silva, MDa,b,∗ (, )
- Michael Southworth, MSb,
- Constantine Raptis, MDc and
- Jonathan Silva, PhDb,∗∗ ()
- aDivision of Pediatric Cardiology, Washington University School of Medicine, St. Louis, Missouri
- bDepartment of Biomedical Engineering, Washington University School of Engineering and Applied Science, St. Louis, Missouri
- cDepartment of Radiology, Washington University School of Medicine, St. Louis, Missouri
- ↵∗Address for correspondence:
Dr. Jennifer N.A. Silva, Division of Pediatric Cardiology, Washington University School of Medicine, 1 Children’s Place, CB 8116 NWT, St. Louis, Missouri 63110-1093.
- ↵∗∗Dr. Jonathan Silva, Department of Biomedical Engineering, Washington University in St. Louis, 1 Brookings Drive, CB 1097, St. Louis, Missouri 63108-1097.
Recently, rapid development in the mobile computing arena has allowed extended reality technologies to achieve performance levels that remove longstanding barriers to medical adoption. Importantly, head-mounted displays have become untethered and are light enough to be worn for extended periods of time, see-through displays allow the user to remain in his or her environment while interacting with digital content, and processing power has allowed displays to keep up with human perception to prevent motion sickness. Across cardiology, many groups are taking advantage of these advances for education, pre-procedural planning, intraprocedural visualization, and patient rehabilitation. Here, we detail these applications and the advances that have made them possible.
This work was funded by Children's Discovery Institute Grant CH-II-2017-575. Abbott has provided research support (software) for this project. Dr. Jennifer N.A. Silva has received research support from Medtronic, St. Jude Medical, Abbott, and AliveCor. Drs. Jennifer N.A. Silva and Jonathan Silva serve on the Board of Directors of and are consultants for SentiAR. Dr. Southworth is a SentiAR shareholder. Dr. Jonathan Silva is a Board Director of and consultant for SentiAR. Dr. Raptis has reported that he has no relationships relevant to the contents of this paper to disclose. Drs. Jennifer N.A. Silva and Southworth contributed equally to this work and are joint first authors. Robert Roberts, MD, served as Guest Editor for this paper.
All authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’ institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information, visit the JACC: Basic to Translational Science author instructions page.
- Received August 4, 2017.
- Revision received November 16, 2017.
- Accepted November 22, 2017.
- 2018 The Authors